#Denmark #biotechnology #Water Technology #Kongens Lyngby #Aquaporin A/S

Aquaporin A/S Holds Extraordinary General Meeting

On December 1, 2025, Aquaporin A/S, a pioneering name in water technology, conducted an extraordinary general meeting (EGM) that led to several key resolutions impacting the company’s future. With a focus on innovative solutions for water filtration through biotechnology, Aquaporin is gradually transforming the landscape of water management globally.

The EGM represented a crucial event where significant amendments were proposed and approved regarding the company’s Articles of Association. Among the primary approvals was the authorization for the Board of Directors to increase the share capital by up to a nominal amount of DKK 175,000,000. This increase is applicable until June 30, 2026 and includes provisions for pre-emptive rights for existing shareholders at prices potentially below market value.

Key Decisions Made

The specific points addressed during the meeting included:
1. The proposal to amend the Articles of Association, granting the Board the authority to raise capital with pre-emptive rights for existing shareholders.
2. An additional proposal was approved, allowing the Board to increase capital without pre-emptive rights but at or above market price.
3. Furthermore, the meeting sanctioned a capital increase without pre-emptive rights aimed at benefiting new investors and parties other than existing shareholders and employees, at prices that may also be below market.
4. Lastly, all proposals were unified under a consolidated maximum limit of nominally DKK 175,000,000, encompassing the first and third authorizations.

Remarkably, all proposals passed with over 99% of the votes cast, reflecting the confidence stakeholders have in Aquaporin's strategic direction and potential for growth.

Aquaporin’s Vision and Future Plans

Aquaporin A/S is committed to rethinking water filtration by incorporating unique biotechnological innovations. With headquarters in Denmark and operations spread across Singapore, Turkey, the United States, and China, the company is aligning its strategies not just to address domestic needs but also to cater to global water challenges effectively. Their technology is fundamentally rooted in Nobel Prize-winning research, translating scientific advancements into viable water purification solutions.

The Aquaporin Inside® technology, a product of this innovative thinking, is integral to their membranes and solutions, targeting applications in both domestic and industrial sectors. This technology is pivotal in ensuring cleaner water for various industries and even finds applications in space missions carried out by NASA. Utilizing collaborative efforts with global partners, Aquaporin aims to address extensive water quality challenges, ranging from treating industrial wastewater to enhancing the accessibility of drinking water.

Conclusion

The extraordinary general meeting marks a significant milestone in Aquaporin’s journey, as it positions the company to leverage innovative capital strategies to enhance its growth trajectory. With a strong backing from shareholders and a clear vision for the future, Aquaporin A/S is set to continue its quest in reshaping how water is treated and perceived, leading to a more sustainable future for all.